ARCHIVES

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Sprycell Approved for CML

November 5, 2010

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

In Brief: LENORA JOHNSON Was Named Director Of Health Education, Communications, And Science Policy at the National Heart Lung and Blood Institute

December 17, 2013

In Brief: Top Frederick Job Draws 90 Applicants, With List Now Down to four; New Members Named To NCAB

June 21, 1974

NCI To Test 5,000 DC-Area Jews To Determine Risk Of BRCA 1 Mutation

October 6, 1995